Circular RNAs in hepatocellular carcinoma: Recent advances

doi:10.4251/wjgo.v14.i6.1067

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 14, Issue 6

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (4651)

All Articles published online

The chart showing PDF series, WORD series, HTML series, Figures (1-3) series, Tables (1-1) series.

Item

Count

PDF

212

WORD

HTML

2374

Figures (1-3)

279

Tables (1-1)

278

Sum=3228

Publishing Process of This Article

The chart showing Browse series, Download series.

Item

Count

Browse

374

Download

1049

Sum=1423

Jun 15, 2022 (publication date) through Nov 26, 2024

Times Cited of This Article

Times Cited (6)

Journal Information of This Article

Publication Name

World Journal of Gastrointestinal Oncology

ISSN

1948-5204

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Review

World J Gastrointest Oncol. Jun 15, 2022; 14(6): 1067-1085
Published online Jun 15, 2022. doi: 10.4251/wjgo.v14.i6.1067

Circular RNAs in hepatocellular carcinoma: Recent advances

Zhao-Shan Niu, Wen-Hong Wang

Zhao-Shan Niu, Laboratory of Micromorphology, School of Basic Medicine, Qingdao University, Qingdao 266071, Shandong Province, China

Wen-Hong Wang, Department of Pathology, School of Basic Medicine, Qingdao University, Qingdao 266071, Shandong Province, China

Author contributions: Niu ZS wrote, revised and proofread this paper; Wang WH consulted the relevant literature in this field.

Conflict-of-interest statement: All the authors report no relevant conflicts of interest for this article.

Open-Access: This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0/

Corresponding author: Zhao-Shan Niu, MD, Associate Professor, Laboratory of Micromorphology, School of Basic Medicine, Qingdao University, No. 1 Ningde Road, Qingdao 266071, Shandong Province, China. z.s.niu@qdu.edu.cn

Received: August 19, 2021
Peer-review started: August 19, 2021
First decision: September 12, 2021
Revised: September 22, 2021
Accepted: May 26, 2022
Article in press: May 26, 2022
Published online: June 15, 2022
Processing time: 294 Days and 16.8 Hours

Core Tip

Core Tip: Current studies have shown that aberrantly expressed circular RNAs (circRNAs) play crucial roles in hepatocellular carcinoma (HCC) by affecting the proliferation, apoptosis and invasive capacity of HCC cells. Certain circRNAs may be used as potential biomarkers to diagnose and predict the prognosis of HCC. Therefore, circRNAs are expected to become novel biomarkers and therapeutic targets for HCC. Herein, we briefly review the characteristics and biological functions of circRNAs, focusing on their roles in HCC to provide new insights for the early diagnosis and targeted therapy of HCC.